中枢神经系统疾病与I型干扰素信号增强相关
本文综述了I型干扰素信号异常与中枢神经系统疾病的关系,包括罕见I型干扰素病和常见神经退行性疾病(如帕金森病、阿尔茨海默病和肌萎缩侧索硬化)。近期研究进展涉及这些疾病的发病机制、诊断和管理,提示靶向I型干扰素及其信号通路具有未来治疗潜力。
要点
- I型干扰素介导的天然免疫反应对防御嗜神经病毒至关重要,但具有神经毒性潜能。
- 自身核酸可触发I型干扰素产生,大脑易受I型干扰素信号不当上调的影响。
- I型干扰素稳态失调与罕见的先天性免疫错误(I型干扰素病)及常见神经退行性疾病相关。
核心结论
- I型干扰素在脑细胞健康中的作用提示靶向这些干扰素及其信号通路的方法具有未来治疗潜力。
研究设计与样本
- 综述,检索范围未明确报告。
主要发现
- I型干扰素稳态失调与罕见的先天性免疫错误(称为I型干扰素病)及更常见的神经退行性疾病(如帕金森病、阿尔茨海默病和肌萎缩侧索硬化)相关。
- 近期进展包括对这些涉及I型干扰素信号失调的疾病发病机制的新见解,以及其诊断和管理方面的进步。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The ability to mount an interferon-mediated innate immune response is essential in protection against neurotropic viruses, but antiviral type I interferons also have neurotoxic potential. The production of type I interferons can be triggered by self-derived nucleic acids, and the brain can be susceptible to inappropriate upregulation of type I interferon signalling. Homoeostatic dysregulation of type I interferons has been implicated in rare inborn errors of immunity (referred to as type I interferonopathies) and more common neurodegenerative disorders (eg, Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis). Recent developments include new insights into the pathogenesis of these disorders that involve dysregulated type I interferon signalling, as well as advances in their diagnosis and management. The role of type I interferons in brain cellular health suggests the future therapeutic potential of approaches that target these interferons and their signalling.
引用
- Crow YJ. CNS disease associated with enhanced type I interferon signalling. Lancet Neurol. 2024. PMID: 39424561. doi:10.1016/S1474-4422(24)00263-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。